Nicole Sweeny, Director of Monopar Therapeutics MNPR, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $240.5K. The latest trade was on 06/26.

NS

NS

Nicole Sweeny

Director

Company

Monopar Therapeutics MNPR

First filing

23/02/13

Trades

36 trades

Buys / sales

0 / 7

12-month net buying

−$240.5K

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
KP KalVista Pharmaceuticals	Open-market sale	05/26	05/27	1,489 sh	$26.78	$39,875.42	−2.4%
KP KalVista Pharmaceuticals	Open-market sale	05/22	05/26	1,861 sh	$26.78	$49,837.58	−3.2%
KP KalVista Pharmaceuticals	Open-market sale	04/17	04/20	1,862 sh	$20.22	$37,649.64	−3.5%
KP KalVista Pharmaceuticals	Open-market sale	02/23	02/24	3,975 sh	$15.57	$61,890.75	−7.8%
KP KalVista Pharmaceuticals	Open-market sale	25/11/24	25/12/04	3,813 sh	$13.45	$51,284.85	−8.8%
KP KalVista Pharmaceuticals	Open-market sale	25/08/25	25/08/26	1,480 sh	$13.42	$19,861.6	−4.4%
KP KalVista Pharmaceuticals	Open-market sale	25/08/22	25/08/25	1,864 sh	$13.22	$24,642.08	−6.1%